Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free
free
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Antiretroviral medications disrupt microglial phagocytosis of beta-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders Giunta B; Ehrhart J; Obregon DF; Lam L; Le L; Jin J; Fernandez F; Tan J; Shytle RDMol Brain 2011[Jun]; 4 (1): 23Up to 50% of long-term HIV infected patients, including those with systemically well-controlled infection, commonly experience memory problems and slowness, difficulties in concentration, planning, and multitasking. Deposition of Abeta plaques is also a common pathological feature of HIV infection. However, it is not clear whether this accumulation is due to AD-like processes, HIV-associated immunosuppression, Tat protein-induced Abeta elevations, and/or the effects of single highly active antiretroviral therapy (ART). Here we evaluated the effects of several ART medications (Zidovudine, Lamivudine, Indinavir, and Abacavir) alone and in combination on: 1) Abeta1-40, 42 generation in murine N2a cells transfected with the human "Swedish" mutant form of APP; 2) microglial phagocytosis of FITC-Abeta1-42 peptides in cultured murine N9 microglia. We report for the first time that these antiretroviral compounds (10 muM) generally increase Abeta generation (~50-200%) in SweAPP N2a cells and markedly inhibit microglial phagocytosis of FITC-Abeta1-42 peptides in murine microglia. The most significant amyloidogenic effects were observed with combined ART (p < 0.05); suggesting certain ART medications may have additive amyloidogenic effects when combined. As these antiretroviral compounds are capable of penetrating the blood brain barrier and reaching the concentrations employed in the in vitro studies, these findings raise the possibility that ART may play a casual role in the elevated Abeta found in the brains of those infected with HIV. Therefore these compounds may consequently contribute to cognitive decline observed in HIV associated neurocognitive disorders (HAND).|*HIV-1[MESH]|*Microglia/drug effects/physiology[MESH]|*Neurons/metabolism/pathology[MESH]|AIDS Dementia Complex/*pathology/physiopathology[MESH]|Amyloid beta-Peptides/*metabolism[MESH]|Anti-Retroviral Agents/*pharmacology/therapeutic use[MESH]|Cell Line[MESH]|Cognition Disorders/pathology/physiopathology[MESH]|HIV Infections/drug therapy/pathology[MESH]|Humans[MESH]|Phagocytosis/*drug effects[MESH] |